Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
650 participants
INTERVENTIONAL
2012-08-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
glue fixation
Optilene™ mesh 60 g/m2 (B. Braun), fixation Histoacryl™ cyanoacrylate glue (price 14+37 euros)
Histoacryl
cyanoacrylate glue fixation of mesh 1 ml
self-gripping
ProGrip™ mesh 60 g/m2 (Covidien, USA) (price 113 euros)
Progrip
self-gripping mesh
suture fixation
Ultrapro™ mesh 28 g/m2 (Ethicon, USA) (price 45 euros) fixated by non-absorbable sutures
sutures (prolene 3-0)
non-absorbable suture fixation 3-0
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Histoacryl
cyanoacrylate glue fixation of mesh 1 ml
Progrip
self-gripping mesh
sutures (prolene 3-0)
non-absorbable suture fixation 3-0
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unilateral or bilateral
Exclusion Criteria
* massive scrotal hernia
* allergy to polypropylene
* patient's refusal
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Paijat-Hame Hospital District
OTHER
North Karelia Central Hospital
OTHER
East Savo Hospital District
OTHER
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hannu Paajanen
PhD, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hannu EK Paajanen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kuopio University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuopio University Hospital
Kuopio, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hannu EK Paajanen, MD, PhD
Role: primary
Kirsi Rönkä, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH 31//2012
Identifier Type: REGISTRY
Identifier Source: secondary_id
KUH5200627
Identifier Type: -
Identifier Source: org_study_id